Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Determinants of pulse wave velocity index and potential implementations.

Stavropoulos K, Imprialos KP, Faselis C, Karagiannis A, Papademetriou V.

J Clin Hypertens (Greenwich). 2019 Sep 3. doi: 10.1111/jch.13661. [Epub ahead of print] No abstract available.

2.

Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial.

Lam PH, Packer M, Fonarow GC, Faselis C, Allman RM, Morgan CJ, Singh S, Pitt B, Ahmed A.

Am J Med. 2019 Aug 8. pii: S0002-9343(19)30615-1. doi: 10.1016/j.amjmed.2019.06.053. [Epub ahead of print]

PMID:
31401165
3.

Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Arundel C, Lam PH, Gill GS, Patel S, Panjrath G, Faselis C, White M, Morgan CJ, Allman RM, Aronow WS, Singh SN, Fonarow GC, Ahmed A.

J Am Coll Cardiol. 2019 Jun 25;73(24):3054-3063. doi: 10.1016/j.jacc.2019.04.022.

PMID:
31221253
4.

Opioid Use and Outcomes in Hospitalized Older Patients With Heart Failure Receiving and Not Receiving Hospice Referrals.

Sheriff HM, Arundel C, Gill GS, Tummala LS, Zeng Q, Theisen-Toupal JC, Morgan CJ, Faselis C, Allman RM, Singh S, Ahmed A.

Am J Ther. 2019 May 24. doi: 10.1097/MJT.0000000000000987. [Epub ahead of print]

PMID:
31145140
5.

Microvascular complications of type 2 diabetes mellitus.

Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K.

Curr Vasc Pharmacol. 2019 May 1. doi: 10.2174/1570161117666190502103733. [Epub ahead of print]

PMID:
31057114
6.

Primary aldosteronism: novel insights.

Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, Doumas M.

Curr Hypertens Rev. 2019 Apr 15. doi: 10.2174/1573402115666190415155512. [Epub ahead of print]

PMID:
30987572
7.

Mineralocorticoid Receptor Antagonists in Essential and Resistant Hypertension.

Imprialos KP, Bouloukou S, Kerpiniotis G, Katsimardou A, Patoulias D, Bakogiannis C, Faselis C.

Curr Pharm Des. 2018;24(46):5500-5507. doi: 10.2174/1381612825666190306163310.

PMID:
30848188
8.

Cardiorespiratory fitness, body mass index and heart failure incidence.

Kokkinos P, Faselis C, Franklin B, Lavie CJ, Sidossis L, Moore H, Karasik P, Myers J.

Eur J Heart Fail. 2019 Apr;21(4):436-444. doi: 10.1002/ejhf.1433. Epub 2019 Feb 19.

PMID:
30779281
9.

Renin-Angiotensin Inhibition and Outcomes in Nursing Home Residents With Heart Failure.

Arundel C, Sheriff HM, Lam PH, Mohammed SF, Jones LG, Jurgens CY, Morgan CJ, Faselis C, Allman RM, Fonarow GC, Ahmed A.

Am J Ther. 2018 Oct 31. doi: 10.1097/MJT.0000000000000836. [Epub ahead of print]

PMID:
30299270
10.

Is very low LDL-C harmful?

Faselis C, Imprialos K, Grassos H, Pittaras A, Kallistratos M, Manolis A.

Curr Pharm Des. 2018;24(31):3658-3664. doi: 10.2174/1381612824666181008110643.

PMID:
30295187
11.

Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction.

Bayoumi E, Lam PH, Dooley DJ, Singh S, Faselis C, Morgan CJ, Patel S, Sheriff HM, Mohammed SF, Palant CE, Pitt B, Fonarow GC, Ahmed A.

Am J Med. 2019 Jan;132(1):71-80.e1. doi: 10.1016/j.amjmed.2018.09.011. Epub 2018 Sep 19.

PMID:
30240686
12.

Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.

Tsimploulis A, Lam PH, Arundel C, Singh SN, Morgan CJ, Faselis C, Deedwania P, Butler J, Aronow WS, Yancy CW, Fonarow GC, Ahmed A.

JAMA Cardiol. 2018 Apr 1;3(4):288-297. doi: 10.1001/jamacardio.2017.5365. Erratum in: JAMA Cardiol. 2018 Apr 1;3(4):358.

13.

Mineralocorticoid Receptor Antagonists in Cardiovascular Medicine: Looking for the Forest Among the Trees.

Stavropoulos KV, Imprialos KP, Doumas M, Faselis CJ.

Curr Pharm Des. 2018;24(46):5489-5490. doi: 10.2174/138161282446190426120024.

PMID:
31068122
14.

Cardiorespiratory Fitness and Health Outcomes: A Call to Standardize Fitness Categories.

Kokkinos P, Myers J, Franklin B, Narayan P, Lavie CJ, Faselis C.

Mayo Clin Proc. 2018 Mar;93(3):333-336. doi: 10.1016/j.mayocp.2017.10.011. Epub 2017 Nov 22.

PMID:
29174511
15.

Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension.

Doumas M, Tsioufis C, Fletcher R, Amdur R, Faselis C, Papademetriou V.

J Am Heart Assoc. 2017 Nov 3;6(11). pii: e007131. doi: 10.1161/JAHA.117.007131.

16.

Impact of Cardiorespiratory Fitness on Mortality in Black Male Veterans With Resistant Systemic Hypertension.

Narayan P, Doumas M, Kumar A, Faselis CJ, Myers JN, Pittaras A, Kokkinos PF.

Am J Cardiol. 2017 Nov 1;120(9):1568-1571. doi: 10.1016/j.amjcard.2017.07.055. Epub 2017 Jul 31.

PMID:
28886854
17.

NAFLD-NASH: An Under-Recognized Epidemic.

Jennings J, Faselis C, Yao MD.

Curr Vasc Pharmacol. 2018;16(3):209-213. doi: 10.2174/1570161115666170622074007. Review.

PMID:
28676024
18.

Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.

Stavropoulos K, Imprialos K, Pittaras A, Faselis C, Narayan P, Kokkinos P.

Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835. Review.

PMID:
28637408
19.

Cardiorespiratory Fitness and Reclassification of Risk for Incidence of Heart Failure: The Veterans Exercise Testing Study.

Myers J, Kokkinos P, Chan K, Dandekar E, Yilmaz B, Nagare A, Faselis C, Soofi M.

Circ Heart Fail. 2017 Jun;10(6). pii: e003780. doi: 10.1161/CIRCHEARTFAILURE.116.003780.

PMID:
28572213
20.

Cardiorespiratory Fitness and Incidence of Type 2 Diabetes in United States Veterans on Statin Therapy.

Kokkinos P, Faselis C, Narayan P, Myers J, Nylen E, Sui X, Zhang J, Lavie CJ.

Am J Med. 2017 Oct;130(10):1192-1198. doi: 10.1016/j.amjmed.2017.04.042. Epub 2017 May 25.

PMID:
28552431
21.

Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16].

Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A.

Int J Cardiol. 2017 Jul 1;238:181. doi: 10.1016/j.ijcard.2017.04.072. Epub 2017 May 6. No abstract available.

PMID:
28487149
22.

Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.

Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A.

Int J Cardiol. 2017 May 15;235:11-16. doi: 10.1016/j.ijcard.2017.02.139. Epub 2017 Mar 1. Erratum in: Int J Cardiol. 2017 Jul 1;238:181.

23.

Impact of Acute Kidney Injury in Patients Hospitalized With Pneumonia.

Chawla LS, Amdur RL, Faselis C, Li P, Kimmel PL, Palant CE.

Crit Care Med. 2017 Apr;45(4):600-606. doi: 10.1097/CCM.0000000000002245.

PMID:
28291091
24.

Left ventricular hypertrophy in athletes and hypertensive patients.

Lovic D, Narayan P, Pittaras A, Faselis C, Doumas M, Kokkinos P.

J Clin Hypertens (Greenwich). 2017 Apr;19(4):413-417. doi: 10.1111/jch.12977. Epub 2017 Mar 1. Review.

25.

Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun.

Faselis C, Boutari C, Doumas M, Imprialos K, Stavropoulos K, Kokkinos P.

Curr Pharm Des. 2017;23(10):1540-1550. doi: 10.2174/1381612823666170206154706. Review.

PMID:
28176630
26.

SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.

Imprialos K, Faselis C, Boutari C, Stavropoulos K, Athyros V, Karagiannis A, Doumas M.

Curr Pharm Des. 2017;23(10):1510-1521. doi: 10.2174/1381612823666170124123927. Review.

PMID:
28120716
27.

Cardiorespiratory Fitness and Incidence of Major Adverse Cardiovascular Events in US Veterans: A Cohort Study.

Kokkinos PF, Faselis C, Myers J, Narayan P, Sui X, Zhang J, Lavie CJ, Moore H, Karasik P, Fletcher R.

Mayo Clin Proc. 2017 Jan;92(1):39-48. doi: 10.1016/j.mayocp.2016.09.013. Epub 2016 Nov 19.

PMID:
27876315
28.

Reduction of Clinical Culture Contamination in an Inpatient Medical Unit by Revisiting Microbiology Education.

Yoon B, Irmler M, Faselis C, Liappis AP.

J Contin Educ Nurs. 2016 Oct 1;47(10):446-448. doi: 10.3928/00220124-20160920-05.

PMID:
27699432
29.

High serum creatinine nonlinearity: a renal vital sign?

Palant CE, Chawla LS, Faselis C, Li P, Pallone TL, Kimmel PL, Amdur RL.

Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F305-9. doi: 10.1152/ajprenal.00025.2016. Epub 2016 May 18. Review.

30.

Exercise Capacity and Atrial Fibrillation Risk in Veterans: A Cohort Study.

Faselis C, Kokkinos P, Tsimploulis A, Pittaras A, Myers J, Lavie CJ, Kyritsi F, Lovic D, Karasik P, Moore H.

Mayo Clin Proc. 2016 May;91(5):558-66. doi: 10.1016/j.mayocp.2016.03.002. Epub 2016 Apr 8.

PMID:
27068670
31.

Improvement in All-Cause Mortality With Blood Pressure Control in a Group of US Veterans With Drug-Resistant Hypertension.

Fatemi O, Goa C, Faselis C, Kokkinos P, Papademetriou V.

J Clin Hypertens (Greenwich). 2016 Jan;18(1):33-9. doi: 10.1111/jch.12672. Epub 2015 Oct 6.

32.

Exaggerated Blood Pressure Response to Exercise: Will It Ever Be Ready for Prime Time?

Doumas M, Faselis C, Kokkinos P.

J Clin Hypertens (Greenwich). 2015 Nov;17(11):845-7. doi: 10.1111/jch.12630. Epub 2015 Aug 3. No abstract available.

33.

Exercise capacity and risk of chronic kidney disease in US veterans: a cohort study.

Kokkinos P, Faselis C, Myers J, Sui X, Zhang J, Tsimploulis A, Chawla L, Palant C.

Mayo Clin Proc. 2015 Apr;90(4):461-8. doi: 10.1016/j.mayocp.2015.01.013. Epub 2015 Mar 16.

PMID:
25792243
34.

Non-interventional management of resistant hypertension.

Doumas M, Tsioufis C, Faselis C, Lazaridis A, Grassos H, Papademetriou V.

World J Cardiol. 2014 Oct 26;6(10):1080-90. doi: 10.4330/wjc.v6.i10.1080. Review.

35.

Halting arterial aging in patients with cardiovascular disease: hypolipidemic and antihypertensive therapy.

Papademetriou V, Katsiki N, Doumas M, Faselis C.

Curr Pharm Des. 2014;20(40):6339-49. Review.

PMID:
24953392
36.

Cardiorespiratory fitness and the paradoxical BMI-mortality risk association in male veterans.

Kokkinos P, Faselis C, Myers J, Pittaras A, Sui X, Zhang J, McAuley P, Kokkinos JP.

Mayo Clin Proc. 2014 Jun;89(6):754-62. doi: 10.1016/j.mayocp.2014.01.029.

PMID:
24943694
37.

Age-specific exercise capacity threshold for mortality risk assessment in male veterans.

Kokkinos P, Faselis C, Myers J, Sui X, Zhang J, Blair SN.

Circulation. 2014 Aug 19;130(8):653-8. doi: 10.1161/CIRCULATIONAHA.114.009666. Epub 2014 Jun 17.

PMID:
24938279
38.

Exercise capacity and all-cause mortality in male veterans with hypertension aged ≥70 years.

Faselis C, Doumas M, Pittaras A, Narayan P, Myers J, Tsimploulis A, Kokkinos P.

Hypertension. 2014 Jul;64(1):30-5. doi: 10.1161/HYPERTENSIONAHA.114.03510. Epub 2014 May 12.

PMID:
24821944
39.

Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.

Zwicker JI, Rojan A, Campigotto F, Rehman N, Funches R, Connolly G, Webster J, Aggarwal A, Mobarek D, Faselis C, Neuberg D, Rickles FR, Wun T, Streiff MB, Khorana AA.

J Clin Oncol. 2014 Jun 10;32(17):1792-6. doi: 10.1200/JCO.2013.53.5336. Epub 2014 May 5.

40.

Apelin and relaxin plasma levels in young healthy offspring of patients with essential hypertension.

Papadopoulos DP, Makris T, Perrea D, Zerva K, Tsioufis C, Faselis C, Papademetriou V.

J Clin Hypertens (Greenwich). 2014 Mar;16(3):198-201. doi: 10.1111/jch.12260. Epub 2014 Feb 20.

41.

Using a board game to reinforce learning.

Yoon B, Rodriguez L, Faselis CJ, Liappis AP.

J Contin Educ Nurs. 2014 Mar;45(3):110-1. doi: 10.3928/00220124-20140224-14.

PMID:
24588236
42.

Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans.

Kokkinos P, Faselis C, Myers J, Kokkinos JP, Doumas M, Pittaras A, Kheirbek R, Manolis A, Panagiotakos D, Papademetriou V, Fletcher R.

Am J Hypertens. 2014 Mar;27(3):422-30. doi: 10.1093/ajh/hpt241. Epub 2014 Jan 16.

PMID:
24436326
43.

Association between AKI and long-term renal and cardiovascular outcomes in United States veterans.

Chawla LS, Amdur RL, Shaw AD, Faselis C, Palant CE, Kimmel PL.

Clin J Am Soc Nephrol. 2014 Mar;9(3):448-56. doi: 10.2215/CJN.02440213. Epub 2013 Dec 5.

44.

Heart rate at rest, exercise capacity, and mortality risk in veterans.

Pittaras AM, Faselis C, Doumas M, Myers J, Kheirbek R, Kokkinos JP, Tsimploulis A, Aiken M, Kokkinos P.

Am J Cardiol. 2013 Nov 15;112(10):1605-9. doi: 10.1016/j.amjcard.2013.07.042. Epub 2013 Sep 13.

PMID:
24035162
45.

A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism.

Kleinjan A, Aggarwal A, Van de Geer A, Faselis C, Büller HR, Di Nisio M, Rickles FR, Kamphuisen PW.

Thromb Haemost. 2013 Nov;110(5):959-65. doi: 10.1160/TH13-05-0414. Epub 2013 Aug 15.

PMID:
23945725
46.

Carotid baroreceptor stimulation: a promising approach for the management of resistant hypertension and heart failure.

Doumas M, Faselis C, Kokkinos P, Anyfanti P, Tsioufis C, Papademetriou V.

Curr Vasc Pharmacol. 2014 Jan;12(1):30-7. Review.

PMID:
23905599
47.

The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns.

Faselis C, Doumas M, Kokkinos P, Tsioufis C, Papademetriou V.

Curr Vasc Pharmacol. 2014 Jan;12(1):38-46. Review.

PMID:
23905598
48.

Renal nerve ablation for hypertensive patients with chronic kidney disease.

Papademetriou V, Doumas M, Anyfanti P, Faselis C, Kokkinos P, Tsioufis C.

Curr Vasc Pharmacol. 2014 Jan;12(1):47-54. Review.

PMID:
23905594
49.

Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics.

Nylén ES, Faselis C, Kheirbek R, Myers J, Panagiotakos D, Kokkinos P.

J Clin Endocrinol Metab. 2013 Aug;98(8):3394-401. doi: 10.1210/jc.2013-1431. Epub 2013 Jun 19.

PMID:
23783095
50.

Gender differences in hypertension: myths and reality.

Doumas M, Papademetriou V, Faselis C, Kokkinos P.

Curr Hypertens Rep. 2013 Aug;15(4):321-30. doi: 10.1007/s11906-013-0359-y. Review.

PMID:
23749317

Supplemental Content

Loading ...
Support Center